Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarction
MetadataShow full item record
© 2016Background Door-to-balloon time (DTBT) less than 90 min remains the benchmark of timely reperfusion in ST-elevation myocardial infarction (STEMI). The relative long-term benefit of timely reperfusion in STEMI patients with differing risk profiles is less certain. Thus, we aimed to assess the impact of DTBT on long-term mortality in high- and low-risk STEMI patients. Method We analysed baseline clinical and procedural characteristics of 2539 consecutive STEMI patients who underwent primary percutaneous coronary intervention (PCI) from the Melbourne Interventional Group registry from 2004 to 2012. Patients were classified high risk (HR-STEMI) if they presented with cardiogenic shock, out-of-hospital cardiac arrest (OHCA) or Killip class = 2; or low-risk (LR-STEMI) if there were no high-risk features. We then stratified high- and low-risk patients by DTBT (= 90 min vs. > 90 min) and assessed long-term mortality. Result Of the 2539 patients, 395 (16%) met the high-risk criteria. A DTBT = 90 min was achieved in 43% of HR-STEMI patients and in 55% of LR-STEMI patients. Patients in the HR-STEMI compared to LR-STEMI cohort had higher in-hospital (31% vs. 1%, p < 0.01) and long-term mortality (37% vs. 7%, p < 0.01). A DTBT = 90 min was associated with significant improvements in short- and long-term mortality in both groups. A DTBT = 90 min was an independent multivariate predictor of long-term survival in LR-STEMI (hazard ratio [HR] 0.5, 95% confidence interval [CI] 0.3–0.9, p = 0.02) but not in HR-STEMI (HR 0.7, 95% CI 0.5–1.1, p = 0.11). Conclusion A DTBT = 90 min was associated with improved short- and long-term outcomes in high- and low-risk STEMI patients. However, it was only an independent predictor of long-term survival in LR-STEMI patients.
Showing items related by title, author, creator and subject.
Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stentsWilson, W.; Andrianopoulos, N.; Clark, D.; Duffy, S.; Brennan, A.; Harries, I.; New, G.; Sebastian, M.; Loane, P.; Reid, Christopher; Ajani, A. (2011)The aim was to examine timing, causes, and predictors of death during long-term follow-up after contemporary percutaneous coronary intervention (PCI) using a large multicenter Australian registry. The cohort consisted of ...
Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes?Biswas, S.; Andrianopoulos, N.; Papapostolou, S.; Noaman, S.; Duffy, S.; Lefkovits, J.; Brennan, Angela; Walton, A.; Shaw, J.; Ajani, A.; Clark, D.; Freeman, M.; Hiew, C.; Oqueli, E.; Reid, C.; Stub, D.; Chan, W. (2018)© The Author 2017. Aims The prognosis of patients undergoing percutaneous coronary intervention (PCI) for different subtypes of acute coronary syndromes (ACS) remains unclear. We compared short- and long-term mortality ...
Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in AustraliaWlodarczyk, J.; Ajani, A.; Kemp, D.; Andrianopoulos, N.; Brennan, A.; Duffy, S.; Clark, D.; Reid, Christopher (2015)Background: Major bleeding is a serious complication of percutaneous coronary intervention (PCI). We set out to investigate the incidence of major bleeding and its impact on hospitalisation and long-term mortality. Method: ...